FDA approves alternative to animal testing for Botox

The healthcare company Allergan has received approval from the Food and Drug Administration (FDA) for its in-vitro, cell-based assay for testing its own brand BOTOX® (onabotulinumtoxinA) and BOTOX Cosmetic, which the company estimates will lead to a 95% reduction in animal tests over the next three years.



Read more: http://www.care2.com/causes/fda-approves-alternative-to-animal-testing-for-botox.html#ixzz1RGv6wJEv

Go Back

© 2016 Humane Research Australia (ABN 17 208 630 818)  Terms & Conditions